Shmuel Bentov

Title: Shmuel Bentov: Innovator in Amorphous Calcium Carbonate Technologies

Introduction

Shmuel Bentov is a notable inventor based in M.P. Ha'ela, Israel. He has made significant contributions to the field of materials science, particularly in the development of stable amorphous calcium carbonate compositions. With a total of two patents to his name, Bentov's work has implications in both pharmaceutical and nutraceutical formulations.

Latest Patents

Bentov's latest patents include "Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides" and "Stable amorphous calcium carbonate comprising phosphorylated amino acids." The first patent provides compositions that contain amorphous calcium carbonate (ACC) and at least one phosphorylated peptide, which stabilizes the amorphous form of the calcium carbonate. The peptides can be selected from crustacean proteins, including GAP65, GAP22, GAP21, and GAP12. The second patent similarly focuses on compositions containing ACC and at least one phosphorylated amino acid for stabilization, also aimed at pharmaceutical and nutraceutical applications.

Career Highlights

Shmuel Bentov is associated with Amorphical Ltd., where he continues to innovate in the field of calcium carbonate technologies. His work has garnered attention for its potential applications in various industries, particularly in health-related sectors.

Collaborations

Bentov collaborates with notable colleagues, including Amir Sagi and Amir Berman, who contribute to the research and development efforts at Amorphical Ltd. Their combined expertise enhances the innovative capabilities of the company.

Conclusion

Shmuel Bentov's contributions to the field of amorphous calcium carbonate are significant, with his patents paving the way for advancements in pharmaceutical and nutraceutical formulations. His ongoing work at Amorphical Ltd. continues to impact the industry positively.